# Bio-Techne

> Protein and diagnostics solutions

Business model and tags: B2B, Publicly traded, E-commerce, Manufacturing, Hardware, Multi-product, Pharma & life sciences, Medical devices, Sells to enterprises, Parent company, International operations, Has production sites, Has in-house R&D

## About Bio-Techne

A leading developer and manufacturer of high-quality purified proteins, reagent solutions, diagnostic products, and genomic tools for research and clinical use globally

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Minneapolis, Minnesota, United States
- **Revenue**: $1.2B (FY2026, publicly reported)
- **Website**: [bio-techne.com](https://www.bio-techne.com/)
- **LinkedIn**: [linkedin.com/company/bio-techne](https://www.linkedin.com/company/bio-techne)

## Bio-Techne account plan

Bio-Techne makes life science reagents, instruments and diagnostics; FY2026 net sales $1,215.0 million, about 3,000 staff, being acquired by Merck KGaA.

[Read the Bio-Techne account plan](https://www.tamtam.ai/c/bio-techne/account-plan)

## Bio-Techne in the news

- [Bio-Techne Corp. stock outperforms competitors on strong trading day](https://www.marketwatch.com/data-news/bio-techne-corp-stock-outperforms-competitors-on-strong-trading-day-097ad9c7-383cca738661?mod=mw_quote_news) · marketwatch.com · Jun 8, 2026
  Bio-Techne stock demonstrated market strength by outperforming industry peers during a recent trading day.
- [Bio-Techne Corp. stock outperforms competitors on strong trading day](https://www.marketwatch.com/data-news/bio-techne-corp-stock-outperforms-competitors-on-strong-trading-day-097ad9c7-383cca738661) · marketwatch.com · Jun 8, 2026
  Bio-Techne Corp. stock outperformed its industry rivals during a strong day of market trading.
- [New Bispecific Antibody Characterization Workflow Might Change The Case For Investing In Bio-Techne (TECH)](https://finance.yahoo.com/sectors/healthcare/articles/bispecific-antibody-characterization-workflow-might-211950177.html) · finance.yahoo.com · Jun 8, 2026
  Bio-Techne and Refeyn launched a streamlined protein characterization workflow for bispecific antibodies to drive growth in high-margin instrumentation.

[See all 20 articles](https://www.tamtam.ai/c/bio-techne/news)

## Bio-Techne at a glance

Bio-Techne is a B2B company in the Biotechnology Research industry, headquartered in Minneapolis, Minnesota, United States.

Bio-Techne has 1,001–5,000 employees.

Bio-Techne's revenue is $1.2B (FY2026, publicly reported).

## Frequently asked questions about Bio-Techne

### What is Bio-Techne's revenue?

Bio-Techne's revenue is $1.2B (FY2026, publicly reported).

### How many employees does Bio-Techne have?

Bio-Techne has 1,001–5,000 employees.

### Where is Bio-Techne headquartered?

Bio-Techne is headquartered in Minneapolis, Minnesota, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/bio-techne
